Abstract
The stability of Immunoglobulin G (IgG) affects production, storage and usability, especially in the clinic. The complex thermal and isothermal transitions of IgGs, especially their irreversibilities, pose a challenge to the proper determination of parameters describing their thermodynamic and kinetic stability. Here, we present a reliable mathematical model to study the irreversible thermal denaturations of antibody variants. The model was applied to two unrelated IgGs and their variants with stabilizing mutations as well as corresponding non-glycosylated forms of IgGs and Fab fragments. Thermal denaturations of IgGs were analyzed with three transitions, one reversible transition corresponding to CH2 domain unfolding followed by two consecutive irreversible transitions corresponding to Fab and CH3 domains, respectively. The parameters obtained allowed us to examine the effects of these mutations on the stabilities of individual domains within the full-length IgG. We found that the kinetic stability of the individual Fab fragment is significantly lowered within the IgG context, possibly because of intramolecular aggregation upon heating, while the stabilizing mutations have an especially beneficial effect. Thermal denaturations of non-glycosylated variants of IgG consist of more than three transitions and could not be analyzed by our model. However, isothermal denaturations demonstrated that the lack of glycosylation affects the stability of all and not just of the CH2 domain, suggesting that the partially unfolded domains may interact with each other during unfolding. Investigating thermal denaturation of IgGs according to our model provides a valuable tool for detecting subtle changes in thermodynamic and/or kinetic stabilities of individual domains.
Keywords: differential scanning calorimetry, irreversible transition, multidomain protein, IgG stability, half-life, kinetic stability
Introduction
Immunoglobulins (IgGs) are structurally rather complex molecules. They consist of four polypeptide chains containing multiple intra- and interchain disulfide bonds. The structure of immunoglobulins is composed of a total of 12 domains that interact in a pair-wise fashion, thus forming four heterodimeric and two homodimeric “super-domains” (Fig. 1). These domains can be grouped together in different segments: the two identical antigen-binding Fab fragments are connected via the hinge region with the Fc fragment responsible for the molecule's effector functions—forming the well-known Y-shaped conformation. One of these homodimeric domains in the Fc fragment, namely the CH2 domains, is generally glycosylated at asparagine 297, and the contacts between the domains are entirely mediated by the sugars.
Figure 1.

Structure of analyzed IgGs, having the well-known Y-shaped conformation. Both the Fab as well as the Fc fragment are labeled. Individual domains are shown as differently colored surfaces: VH is represented in dark blue, CH1 in light blue, CH2 in brown, CH3 in green, VL in magenta and CL in pink. The six stabilizing mutations are highlighted within one transparent VH domain as red spheres, the glycan moieties of the CH2 domains are shown in yellow.
Immunoglobulins are very promising candidates in the development of new drugs with many of them already being used successfully in the clinic.1 One of the most important biophysical parameters characterizing these molecules is their stability. In fact, comprehensive knowledge about factors determining or even predicting protein stability in general would clearly facilitate the development of optimal protein frameworks, production conditions as well as solvent formulations. In principle, there are two types of stabilities that need to be taken into consideration: the thermodynamic stability, dealing with equilibrium transitions and describing the stability of the protein as its free energy of unfolding as a function of temperature, as well as the kinetic stability, reflecting irreversible transitions and specifying the stability of the protein as a function of time (determined by rate constant of a rate-limiting irreversible step) with temperature as a parameter.2–4 This kinetic stability can not only determine the shelf-life, but also the in vivo performance of an antibody.
The simplest model describing the thermodynamic stability of a given protein is the two-state model, where the native state (N) is in equilibrium with the denatured state (D):
with K being the equilibrium constant of the reaction. In such a case, removal of denaturation conditions (temperature, chemical denaturants, etc.) causes a shift of the equilibrium toward the N state. Thus, theoretically, the so called half-life of a reversibly unfolding protein is unlimited.
The simplest model for describing the kinetic stability, on the other hand, is a particular case of the Lumry-Eyring model5:
that can be simplified by the following equation:
, where F is the final (denatured) state of the protein, and k and k' are the rate constants of the irreversible steps of this reaction (determining the theoretical half-life of the protein under the given conditions).
In thermal or denaturant-induced denaturations of multidomain proteins such as IgGs, several overlapping transitions—often involving irreversible steps—have to be considered for the determination of the protein's thermal stability. Numerous studies highlight the power of differential scanning calorimetry (DSC) as the method of choice for studying these multidomain proteins.6–8 The major advantage of DSC is its ability to usually discernibly distinguish transitions that are difficult to detect and to differentiate by other methods, such as spectroscopic approaches. This is especially important for the analyses of immunoglobulins, as their thermal transitions consist of two or three peaks that can be ascribed to the reversible denaturation of CH2 domains, the cooperatively irreversible denaturation of the Fab fragments and the cooperatively irreversible denaturation of the CH3 domains.9
Numerous studies on the thermal denaturation of IgGs have been performed, reporting effects of pH,10–15 formulation,16,17 as well as the cooperativity within the IgG molecules.9,10,18,19 Despite the absence of relevant information regarding the number and reversibility of studied transitions, in all these studies thermal transitions of IgGs were analyzed based on deconvolutions using equilibrium transitions. This approach is, however, questionable as the thermal transitions (besides the homodimeric domain CH2) of IgGs are irreversible and thus kinetically driven. Although it has been shown that the thermal denaturation of several proteins, under certain circumstances, can be interpreted in terms of the van't Hoff equation despite their calorimetric irreversibility,20–22 the irreversibility and dependence of thermal denaturation on the used scan rate exclude IgGs from this category.
In the present work, we have created a model and derived appropriate equations that reliably describe all transitions present. As a proof of principle, we applied this model to stability analyses of IgGs with known, well-characterized properties. The obtained results also incorporate kinetic stability data and indicate, partly in contrast to previously published data, that domains “feel” the presence of their neighboring domains, possibly by partially unfolded domains interacting with each other. This is reflected in the interdependence of parameters describing thermal denaturation of IgG variants. This conclusion is further supported by additional results obtained from isothermal denaturation experiments.
Material and Methods
Purification of IgGs
Antibodies were expressed and purified from mammalian cell culture supernatants as described previously.23 Briefly, the supernatants were loaded onto HiTrap Protein A columns (GE Healthcare) at 4°C at a flow rate of 1 mL/min. Chromatography was performed using an ÄKTA PrimePlus chromatography system (GE Healthcare) at 4°C. After loading, the column was washed with 100 mM sodium phosphate buffer pH 8.0 containing 150 mM NaCl. Elution of IgG was accomplished by using 100 mM glycine pH 2.7, followed by immediate neutralization of each fraction to pH 7.5 using 1M Tris, pH 8.0. The concentrations of the sample fractions were determined by UV-spectroscopy at 280 nm with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific), assuming a mass extinction coefficient of 1.37 for a 1 mg/mL solution of IgG. The samples with the highest protein concentration were pooled and dialyzed twice against PBS (Sigma-Aldrich; 10 mM Na2HPO4, 1.8 mM KH2PO4, 2.7 mM KCl, 137 mM NaCl, pH 7.1) at 4°C. After dialysis, the samples were filtered through 0.22 µm filters (Millipore) and stored at 4°C.
Guanidinium chloride-induced equilibrium unfolding measured by intrinsic tryptophan fluorescence (ITF)
Guanidinium chloride (GdmCl)-induced denaturation measurements were carried out with protein/GdmCl mixtures containing a final protein concentration of 1 µM and denaturant concentrations ranging from 0 to 5M (99.5% purity, Fluka, MO). These mixtures were prepared from a 6M GdmCl stock solution (in PBS, pH adjusted to 7.1) and equilibrated for up to 7 days at 25°C. Each final concentration of GdmCl was determined by measuring the refractive index. The intrinsic fluorescence emission spectra were then recorded from 300 to 400 nm with an excitation wavelength of 295 nm in an Infinite M1000 reader (Tecan, NC). Individual GdmCl blanks were recorded and automatically subtracted from the data.
ANS measurements
Samples of different antibody formats were mixed with 200 μM 8-anilino-naphthalene-1-sulfonic acid (ANS) and incubated for 7 days at room temperature. The fluorescence emission spectra were recorded from 430 to 550 nm with an excitation wavelength of 390 nm in an Infinite M1000 reader (Tecan, NC) and averaged over 10 accumulations.
Differential scanning calorimetry
DSC measurements were performed using a VP-Capillary DSC system (Microcal, acquired by Malvern Instruments Ltd). The antibody concentrations were adjusted to 0.5 mg/mL before the measurement unless otherwise stated. The corresponding buffer was used as a reference. The samples were heated from 15°C to 100°C at the stated rates after initial 8 min of equilibration at 15°C. A filtering period of 10 s was used and data were analyzed using Origin 7.0 software (OriginLab Corporation, MA). Thermograms were corrected by subtraction of buffer-only scans and then normalized to the molar concentration of the protein.
Analysis of DSC scans
The experimental data of the excess heat capacity of IgG obtained from DSC were fitted by Eq. 28 (see Appendix). The experimental data of the excess heat capacity of Fab fragments were fitted by Eq. 9. DSC data were analyzed by numerical analysis in Microsoft Excel® by nonlinear regression using the Solver Add-in. Regression statistics for regression coefficients (the standard deviations of the regression coefficients and R2), obtained by using the Solver Add-in, were calculated by utilizing the SolvStat Add-in.
Results
For analyzing the stability aspects of various formats and constructs, we chose a set of already well-characterized antibodies, IgG6B3 and IgG2C2, that contain the same heavy chain subclass (VH6) but dissimilar light chains, Vκ3 in IgG2C2 and Vλ3 in IgG6B3.23,24 Next to the original IgG (WT for wild type), an engineered variant with framework mutations in VH (M for mutant) of the otherwise identical IgG, displaying improved biophysical properties, was analyzed as well. All point mutations present in the engineered antibodies (Q5V, S16G, T58I, V72D, S76G, and S90Y) are located outside the CDRs in the VH framework (Fig. 1), and thus in the Fab fragment of the IgG.
Effect of the mutations and of a lack of glycosylation on thermal stability of antibodies
The effect of the mutations and lack of glycosylation on the thermal stability of IgG6B3 and Fab6B3 variants was assessed by DSC experiments (Fig. 2). As previously shown, the six point mutations present in the VH domain of the engineered antibodies have a stabilizing effect on both the Fab6B3 fragment as well as the whole IgG6B3 molecule (Fig. 2).23 While thermal denaturation of the whole IgG6B3 is at least a two-step process (as indicated by two peaks), DSC scans of the Fab6B3 fragment consist of only one peak, indicating a one-step transition. The stabilization effect of the mutations on the Fab6B3 fragment is apparent from the shift of the transition temperature, Ttrs, of Fab6B3WT from 72.8°C to 76.5°C measured for Fab6B3M. This improved stability also holds true within the IgG6B3 context. The DSC profile of thermal transition of IgG6B3WT consists of a high and broad peak at Ttrs = 71.5°C followed by a small peak at Ttrs = 81.8°C [Fig. 2(A)]. The mutations in IgG6B3M cause two apparent changes to the thermal transitions of IgG6B3: (i) the first peak becomes asymmetric with a shoulder at the leading side of the peak, and (ii) the main transition shifts to higher temperature with Ttrs = 74.4°C. The position and apparent enthalpy of the subsequent transition at Ttrs∼82°C is unaffected by the mutations (Fig. 2).
Figure 2.

Thermal denaturation of different antibody IgG6B3 formats monitored by DSC. (A) IgG6B3WT (black), Fab6B3WT (blue), and IgG6B3WTΔ (red); (B) IgG6B3M (black), Fab6B3M (blue), and IgG6B3MΔ (red). In all cases, DSC experiments were performed with 0.5 mg/mL of protein in PBS buffer, pH 7.4 at a scan rate of 1.0 K/min.
The effect of absence of glycosylation on protein stability was investigated with glycan-knock-outs of IgG, referred to as IgGWTΔ and IgGMΔ, respectively. These variants do not possess the NxT motif, responsible for N-linked glycosylation at Asn297, due to replacement of threonine at position 299 by alanine.23 In both non-glycosylated forms of IgG6B3 (WT and M), the lack of glycosylation is accompanied by an appearance of an additional transition at ∼62°C (Fig. 2). Both forms thus undergo now three distinct thermally induced transitions: IgG6B3WTΔ at Ttrs∼62°C, ∼72.5°C, ∼82°C and IgG6B3MΔ at Ttrs∼62°C, ∼74.5°C, ∼82°C. The existence of three transitions in thermal denaturation of IgG is in agreement with previously published findings, stating that thermal denaturation of immunoglobulins proceeds through three subsequent transitions, corresponding (from low to high temperatures) to (i) the CH2 domains, (ii) the Fab fragment, and finally (iii) CH3 domains.9,25,26
Detailed analyses of thermal denaturation of the studied antibodies showed that their thermal denaturations are both scan-rate-dependent (Fig. 3) and become irreversible upon heating to ∼90°C (data not shown). Thermally denatured antibodies are incapable to properly refold due to their aggregation in the process of thermal denaturation.27 Interestingly, the thermal transitions are, however, independent of protein concentration, as even a 10-fold increase (from 0.25 to 2.5 mg/mL) in protein concentration has no apparent effect on DSC chromatograms (Supporting Information Fig. S1). The observed lack of dependence of the transition temperature on protein concentration indicates that the oligomerization/aggregation is not part of the rate-limiting irreversible reaction.5,28 Furthermore, the aggregation reaction may involve intramolecular associations of partially unfolded domains.
Figure 3.

Thermal denaturations of IgG6B3s and Fab6B3 fragments as a function of scan rate monitored by DSC: Data from (A) IgG6B3WT, (B) Fab6B3WT, (C) IgG6B3WTΔ, (D) IgG6B3M, (B) Fab6B3M, (C) IgG6B3MΔ indicate that these proteins are under kinetic control. Measurements were performed at three different scan rates: 0.5 K/min (blue), 1.0 K/min (green), and 1.5 K/min (red). Experimental data are shown as dots; theoretical fits based on a global fit according to Eq. 3 for IgGs (boxes A, C, D, and F) and to Eq. 9 for Fab (B and E) are shown as solid lines. In all cases, DSC experiments were performed with 0.5 mg/mL of protein in PBS buffer, pH 7.4.
Model of thermal denaturation of IgG
Closer analyses of individual thermally induced transitions of the whole IgG (studied in this work) and analogous IgGs (unpublished data) show that the first transition, corresponding to the CH2 domains, is reversible, in agreement with previously published findings.29 However, this holds true only when heating is stopped during or right after the first transition (∼72°C for glycosylated IgGs) and the sample is (quickly) re-cooled to pre-transition temperatures. If the protein is held at post-transition temperatures (of the first transition) for too long and/or the heating continues to higher temperatures, the transition becomes irreversible as well.
Thermal denaturation of IgG based on analyses of numerous IgGs can be described by three consecutive transitions (one reversible followed by two irreversible transitions) and is expressed by Eq. 1:
| 1 |
where N is the native state, U and D are intermediate states of thermal denaturation and F is the final (denatured) state of IgG; K is the equilibrium constant of the first transition, k2 and k3 are rate constants of the corresponding irreversible reactions. The excess heat capacity, which is the parameter measured in the DSC experiments, is expressed by the general equation satisfying the model:
| 2 |
where ΔH1, ΔH2, and ΔH3 are molar enthalpy changes for the first, second and third steps, respectively; nN, nU, and nD are molar fractions of corresponding states of the protein and v is the scan rate in K/min. Substitution of molar fractions by derived equations (see Appendix) leads to the equation:
![]() |
3 |
where
Detailed description of the derivation of Eq. 3 is provided in the Appendix.
For fitting the thermal transition of Fab fragments consisting only of a one-step irreversible transition, the following equation was used5,30:
| 9 |
where the fitting parameters have the same meaning as defined above. The subscript 2 is used to highlight that the description of this thermal denaturation is in agreement with the description of this step within the whole IgG molecule (refer to Eq. 1).
Analysis of thermal denaturation of the proteins
The DSC scans of IgG6B3 and Fab6B3 were analyzed by using Eqs. 3 and 9, respectively. Fits were excellent in most cases. Fitting parameters of individual fits are listed in Table S1 in the Supporting information. However, in order for the model to be an adequate description of the thermal denaturation, there must be consistency between the fits achieved for the DSC profiles obtained at different scan rates. The data were therefore fitted globally, that is, parameters characterizing the reversible transition such as ΔH (calorimetric enthalpy) and T1/2 (transition temperature) as well as the parameters of the irreversible steps like Ea (activation energy) and T* (temperature at which the rate of an irreversible step is equal 1 min−1) were forced to be the same for all scan rates. Fitting parameters obtained from global fits are listed in Table1 and the fits are shown in Figure 3. These fits are in very good agreement with the experimental data (based on correlation coefficients as well as on visual inspection) for all IgGs and Fab fragments, thus indicating thus a robustness of the model. Interestingly, they are consistently worse for the non-glycosylated counterparts of IgGs, suggesting that the thermal denaturation of non-glycosylated IgG is more complex than the derived model, potentially containing additional irreversible steps.
Table 1.
Fitting Parameters for Thermal Transitions of IgGs and Fab Fragments Obtained From Global Fits of Experimental Data to Eqs. 3 and 9, Respectively
| Protein | T1/2 (°C) | ΔH1 (kJ/mol) |
(°C) |
Ea2 (kJ/mol) | Half-life factora |
(°C) |
Ea3 (kJ/mol) |
|---|---|---|---|---|---|---|---|
| IgG6B3WT | 69.9 | 517 | 76.1 | 202 | 1 | 84.9 | 348 |
| IgG6B3M | 69.9 | 584 | 75.7 | 542 | 2 × 106 | 84.5 | 358 |
| Fab6B3WT | n.a. | n.a. | 75.2 | 427 | 1 × 104 | n.a. | n.a. |
| Fab6B3M | n.a. | n.a. | 77.7 | 615 | 1 × 108 | n.a. | n.a. |
| IgG2C2WT | 69.7 | 480 | 88.8 | 106 | 0.05 | 88.5 | 325 |
| IgG2C2M | 69.6 | 632 | 86.7 | 294 | 1 × 104 | 90.0 | 357 |
The half-life factor is expressed as approximate factors relative to the half-life of IgG6B3WT at 37°C.
n.a. – not applicable.
Fitting parameters obtained from thermal denaturations of Fab6B3WT and Fab6B3M unambiguously show the stabilization effect of the mutations (Table1). Both parameters characterizing the rate constant, that is, T* and Ea, increased by 2.5°C and ∼200 kJ/mol, respectively. The increase in these parameters results in a ∼10'000-fold increase in kinetic stability, expressed as the “half-life” of the Fab fragment at 37°C, calculated as τ=ln2/k2. Interestingly, the mutations have even a higher relative kinetic stabilization effect when the Fab fragment is part of the whole IgG. While this is not apparent in the very similar
, the activation energy Ea2 of the Fab fragment in the IgG context appears higher (Table1). A treatment of this step as a reversible transition would thus not notice the change within the Fab fragment, but the measurements at different scan rates have uncovered this. While indeed the Fab fragment is separated from the Fc part and from the other Fab fragment by the hinge region, the partially denatured Fab fragments may aggregate with each other for the wild type, but less so for the mutant, making the differentiation between wild type and mutant much larger than for the Fab fragment. This hypothesis of an intramolecular “aggregation” upon heating within the IgG is also consistent with the lack of concentration dependence (Supporting Information Fig. S1). The calculated half-life for the IgG6B3WT is ∼3 days at 37°C, while the kinetic stability of IgGM is increased by 6 orders of magnitude.
The model was also applied in the analyses of thermal denaturations of an unrelated antibody, IgG2C2WT and its variant IgG2C2M, containing the same mutations as IgG6B3WT (Fig. 4).23 The thermal denaturations of both IgG2C2WT and IgG2C2M are scan-rate-dependent and proceed in three steps, a first reversible transition followed by two irreversible transitions, in accordance with the model shown in Eq. 1. Analogously, as in the case of IgG6B3, the fits are in very good agreement with experimental data of IgG2C2 (Fig. 4). Comparison of the fitting parameters for individual scans of IgG2C2WT and IgG2C2M (Supporting Information Table S1) as well as the global fits (Table1) show that the mutations in the context of IgG2C2 have a similar stabilizing effect (although about 1 order of magnitude lower than in the context of IgG6B3).
Figure 4.

Thermal denaturations of IgG2C2s as a function of scan rate monitored by DSC: Data from (A) IgG2C2WT, (B) IgG2C2WTΔ, (C) IgG2C2M, (D) IgG2C2MΔ indicate that these proteins are under kinetic control. Measurements were performed at three different scan rates: 0.5 K/min (blue), 1.0 K/min (green), and 1.5 K/min (red). Experimental data are shown as dots; theoretical fits based on a global fit according to Eq. 3 are shown as solid lines for IgG2C2WT/M. DSC scans of non-glycosylated variants were not fitted to our model due to the complex nature of their thermal denaturations. Therefore, only experimental data are shown for the non-glycosylated variants of IgG2C2s. In all cases, DSC experiments were performed with 0.5 mg/mL of protein in PBS buffer, pH 7.4.
Thermal denaturations of IgG2C2WTΔ and IgG2C2MΔ show a more complex process than for their glycosylated variants. The non-glycosylated variants of IgG2C2 undergo thermal denaturation in, at least, 4 steps that are clearly distinguishable in IgG2C2M. Therefore, the derived model cannot be applied for the analysis of thermal denaturations of non-glycosylated IgG2C2 variants.
Isothermal chemical denaturation of antibodies
An alternative way to address protein stability is by isothermal chemical denaturation, usually performed by denaturants such as GdmCl or urea. However, to be able to extract proper thermodynamic parameters (such as ΔGH2O values) for a given protein, its denaturation has to be reversible and in general should not consist of more than two steps. In fact, when isothermal denaturation of a protein proceeds through more than two steps, the obtained fits are usually unreliable due to unresolved, overlapping transitions and/or the presence of “hidden” intermediate states of the protein. Unfortunately, IgGs as well as Fab fragments consist of several similar domains that unfold irreversibly at similar denaturant concentrations. Despite the unsuitable properties of these proteins, we were interested in whether their isothermal denaturations are affected by mutations and/or the lack of glycosylation. Although the obtained results can be considered to be only of qualitative nature, they show stabilization effects for mutations and the glycosylated state of the analyzed IgG6B3s (Fig. 5) as described in the following section.
Figure 5.

Isothermal denaturation of IgG6B3s and Fab6B3 fragments monitored by ITF (circles) and ANS fluorescence (squares) for wild type (blue) and engineered (red) variants: (A) IgG6B3WT and IgG6B3M, (B) Fab6B3WT and Fab6B3M, and (C) IgG6B3WTΔ and IgG6B3MΔ. Numbers in the curves indicate positions of intermediate states detected from the phase diagram analysis (see Supporting information). Connecting lines serve only to lead the eye. All experiments were performed in PBS buffer, pH 7.4.
Isothermal chemical denaturation was performed by monitoring fluorescence both of intrinsic tryptophan residues by intrinsic tryptophan fluorescence (ITF) and of the exogenous fluorescence dye 1-anilinonaphthalene-8-sulfonate (ANS). Both polarity and dynamics of the tryptophan environment change upon denaturation as conformational transitions of the analyzed protein dramatically affect their fluorescence.31 Most tryptophans are hidden from polar solvent in the hydrophobic core of proteins and thus show an emission maximum at ∼330 nm, while the fully solvent-exposed tryptophan residues (upon denaturation of the protein) have their fluorescence maximum at ∼355 nm. Furthermore, some of the tryptophans are close to the intra-domain disulfide bonds and thus are strongly quenched in the native state. The position of the emission maximum as well as the amplitude of fluorescence is thus both sensitive probes for monitoring conformational changes in antibodies. The analyzed IgG6B3 contains 26 tryptophanyl residues in its structure: each VH/VL pair contains 6, each CH1/CL 3, CH2/CH2 totally 4 and CH3/CH3 another 4 tryptophan residues.
On the other hand, ANS is a very weak fluorophore in polar solvents such as water and its fluorescence significantly increases and shifts to shorter wavelengths in hydrophobic environments.32,33 This feature causes a dramatic shift of its emission maximum upon binding of ANS to hydrophobic patches of partially un/folded protein molecules, thus allowing the detection of intermediate structures of IgG6B3s and Fab6B3s during isothermal denaturation with GdmCl.
The analyzed unfolding reactions of the studied proteins happen rather slowly. This observation is in agreement with previously published results,34 stating that it took nearly a month of equilibration until no further changes in the denaturation curve could be observed. As equilibration of the unfolding reaction was not yet reached after 1 day incubation, we re-analyzed the samples again after 7 days incubation (Supporting Information Fig. S2). After 7 days, the intermediate states in protein unfolding can be more easily seen than in data recorded after only 1 day incubation at room temperature. Although the equilibrium has probably not been reached even after this extended incubation, for qualitative comparison and analysis of stabilization effect of mutations these recordings were sufficient.
The obtained data show that isothermal denaturation of all studied proteins, IgG6B3WT/M, Fab6B3WT/M and IgG6B3WTΔ/MΔ, is complex, as the transition of each protein consists of several intermediates (Fig. 5). However, the stabilizing effect of the mutations is clearly apparent for all engineered variants. This conclusion follows from a shift of denaturation curves to higher GdmCl concentrations in a concentration range between 2 and 3M. The distinct transition at ∼1M GdmCl measured by Trp fluorescence (probably belonging to CH2) is unaffected by the mutations (Fig. 5). Interestingly, the complexity of the isothermal unfolding of Fab6B3 fragments is comparable with that of the whole IgG, despite the missing homodimeric domains CH2/CH2 and CH3/CH3 [Fig. 5(B)]. This is likely a result of domain interactions between partially un/folded domains which can occur both in the isolated Fab6B3 fragment and the IgG6B3.
In contrast, ANS fluorescence clearly differentiates between intact IgG6B3s, that is, IgG6B3WT and IgG6B3WTΔ, and the Fab6B3WT fragment. For IgG6B3WT and IgG6B3WTΔ, ANS detects two apparent intermediate states as demonstrated by an emission maximum of ANS fluorescence at ∼495 nm at ∼2.2M GdmCl and ∼505 nm at ∼3M GdmCl [Fig. 5(A,C)], respectively. In the case of Fab6B3WT, only one clearly defined intermediate at ∼2M GdmCl with an emission maximum of ANS fluorescence at ∼490 nm is detectable [Fig. 5(B)]. This observation either indicates that the intermediate at ∼3M GdmCl is not part of the Fab6B3 fragment, or that an intermediate is formed which is stabilized by an interaction with the other domains. Interestingly, binding of ANS is not observed in isothermal unfolding of any protein containing the stabilizing mutations (red squares in Fig. 5).
The complexity of isothermal unfolding of studied IgG6B3 forms was also analyzed in phase diagrams.35–38 The basis of this powerful method in revealing hidden intermediates is a pairwise correlation of two different independently extensive parameters (e.g., spectral intensities) in the same plot. For a two-state transition, the plot of the intensities should be linear, as each spectrum is a linear combination of the spectra of the two states. Any nonlinearity corresponds to the deviation from an all-or-none transition. The number of linear portions (n) indicates n + 1 species. This phase diagram method should be applied to data measured under identical conditions. Here, fluorescence emission intensities at 330 and 365 nm (upon excitation at 295 nm) were interrelated and plotted as F330 versus F365 (Supporting Information Figs. S3–S5). Clearly, the spectral diagrams are not linear, indicating the presence of intermediates and/or partially unfolded states. There are four/five linear regions which suggest at least five/six different species, indicated by numbers in Figure 5 and Supporting Information Figures S3–S5. Interestingly, the mutations just alter the position of intermediate states in the analyzed proteins but do not affect their number, pointing out that the mutations do not change the unfolding reactions — they ‘only’ stabilize the molecules against unfolding.
An intriguing conclusion follows from the comparison of unfolding curves of glycosylated and non-glycosylated forms of IgG6B3WT and IgG6B3M (Fig. 6). Deglycosylation in both proteins, IgG6B3WT and IgG6B3M, causes destabilization of the transition at ∼1M and ∼2.5M GdmCl. Surprisingly, in the case of IgG6B3M the absence of the glycan destabilizes all transitions. This observation might be interpreted as the inter- or intramolecular interaction of partially unfolded domains with each other, thereby stabilizing this partially unfolded state with respect to the pre-transition state.
Figure 6.

Effect of missing glycosylation on isothermal transitions of IgG6B3s monitored by ITF: (A) IgG6B3WT (white) and IgG6B3WTΔ (black), and (B) IgG6B3M (white) and IgG6B3MΔ(black). All experiments were performed in PBS buffer, pH 7.4.
Discussion
Immunoglobulins are multidomain proteins that usually show complex denaturation patterns when denatured either by high temperature or by denaturants. An often occurring complication in proper analyses of thermally and chemically induced denaturations of multidomain proteins is caused by the irreversible nature of the accompanying conformational changes. In such cases, thermodynamic and/or kinetic analyses of such transitions without justified models often lead to incorrect conclusions. In the present work, we studied thermally and chemically induced denaturation of wild-type and engineered IgGs and Fab fragments as well as non-glycosylated forms of the corresponding IgGs.
Analysis of thermal denaturations of antibodies
The analyses of thermal denaturation of Fab6B3 fragments were performed according to an already established model based on a one-step irreversible transition.5,30 However, for the analyses of IgGs, we had to derive a new comprehensive model consisting of at least 3 observable transitions.
Thermal transitions of Fab6B3 fragments monitored by DSC consist of (i) single peaks (Fig. 2), (ii) depend on the used scan rate [Fig. 3(B)] and (iii) are irreversible—observations that are in agreement with previously published work.18,26,39,40 These results provide a strong basis for the analysis of thermal denaturation according to a particular case of the Lumry-Eyring model, consisting of one irreversible step:
, derived by Sanchez-Ruiz and colleagues.5,30 The parameters obtained from these fits clearly show kinetic stabilization of the Fab fragment due to our mutations in the VH domain (Table1). This is demonstrated by a ∼10,000-fold extension of the theoretical half-life of Fab6B3M at 37°C in comparison to Fab6B3WT.
The thermally induced transitions of the whole IgGs, both for IgG6B3 and IgG2C2, are more complex but still can be expressed by the scheme represented by Eq. 1. This model is in agreement with conclusions of the work of Ionescu et al.9 where the authors—based on the study of stability of humanized IgG1—concluded that DSC profiles of IgG1 generally consist of 2 or 3 visible peaks representing unfolding of domains in the following order: CH2 < Fab < CH3 (except for the rare cases of IgGs with extreme Fab stabilities, where they can overlap with CH2 at the low end or CH3 at the high end). The newly derived equation (Eq. 3) for calculating the excess heat capacity enabled us to obtain fitting parameters that characterize all individual transitions of IgG thermal denaturation.
The parameters indicate that the mutations in the Fab6B3 fragment do not influence the first and the third transitions, that is, the unfolding of CH2 and CH3 domains, respectively. In fact, this is exactly what one would expect considering the location of the mutations at the “tip” of the Fab fragment. Interestingly, however, the kinetic stability of all analyzed Fab fragments decreased when they were part of the corresponding full-length IgG6B3. However, while for Fab6B3WT it decreased by ∼4 orders of magnitude, the kinetic stability was reduced only by ∼2 orders of magnitude for Fab6B3M. This suggests that the partially unfolded Fab fragments may interact with each other, as they do not seem to influence the denaturation of either CH2 or CH3, yet behave differently in the IgG than in isolation. Furthermore, the engineering of the Fab fragments, which had originally also been motivated by decreasing aggregation tendency and improving expression in E. coli,24 may also be effective in the context of the IgG, and therefore make the engineered Fabs in the context of the IgG behave more like in isolation. Consequently, the combination of the higher intrinsic kinetic stability of Fab6B3M and its smaller decrease upon incorporation into IgG6B3 results in a ∼6 orders of magnitude higher kinetic stability of IgG6B3M than that of IgG6B3WT (Table1) at 37°C.
Interestingly, the relative stabilizing effect of the mutations is similar also in IgG2C2 despite the different light chain classes in in these antibodies. The different composition of these Fab fragments is apparently the reason of the different (overall) kinetic stabilities of IgG2C2 and IgG6B3 (Table1). Indeed, the thermal denaturations of the CH2 and CH3 domains in IgG2C2 and IgG6B3 are described by similar parameters. The obtained very similar fitting parameters for CH2 and CH3 transitions despite the relatively dissimilar thermal transitions of full-length wild type and mutated IgG6B3 and IgG2C2 indicate the robustness of our model.
Analogous quantitative analyses of non-glycosylated IgGs, however, could not be performed by our model. In the case of non-glycosylated IgG6B3, the fitting was significantly worse for both IgG6B3WTΔ and IgG6B3MΔ, indicating an incompatibility of our model with the thermal denaturations of these forms of IgG6B3 [Figs. 3(C,F)]. Applying a different model, for example, three consecutive irreversible transitions, did not significantly improve the fits (data not shown). Analyses of thermal denaturations of IgG2C2Δ clearly show that the thermal denaturation of these variants proceed through more than 3 steps [Figs. 4(B,D)]. The appearance of another transition(s) in thermal denaturation of non-glycosylated IgGs can in principle indicate either destabilization of the full-length IgGs by missing glycosylation with concomitant additional intramolecular association reactions or inhomogeneity in the purified fraction of the protein. However, studies of the effects of the lack of glycosylation on the stability of Fc fragments41,42 as well as of intact IgGs43,44 are in qualitative consent with our results and indicate destabilization of CH2 domains with additional small effects on the thermal stability of Fab region and CH3 domains.25 While some observations indicate only subtle modification of IgG stability due to the absent glycosylation,43,44 in our hands, the destabilization of the first transition, the unfolding of the CH2 domain, is quite significant. The temperatures of unfolding of the CH2 domains decreased by ∼7–10°C for the studied IgGs.
Analysis of isothermal denaturations of IgG6B3 antibodies
Isothermal denaturation curves can be analyzed only qualitatively due to their high complexity, extremely slow equilibration, and possibility of irreversibility under the experimental conditions. However, the conclusion that one can draw from our kinetic measurements is in agreement with the corresponding thermal denaturation data, that is, that the stability of IgG6B3 domains follow the order (from low to high stability) of CH2 < Fab < CH3. The first transition observed at GdmCl concentration of ∼1M is a result of the unfolding of the CH2 homodimeric domain, although one cannot exclude a contribution of the fluorescence signal from the Fab6B3 fragment. The former conclusion is strongly supported by the fact that non-glycosylated IgGs exhibit a destabilization of this transition [Figs. 5(A,C) and Fig. 6]. The latter conclusion is (at the same time) confirmed by the observation that unfolding of Fab6B3 fragments also contains a small transition in this concentration range [Fig. 5(B)]. A set of transitions between ∼1.5M and 3.0M GdmCl corresponds to an unfolding of the Fab region, as clearly follows from the unfolding of Fab6B3 fragment shown in Figure 5(B). Finally, the unfolding of the CH3 domains very likely proceeds at GdmCl concentrations >2.5M. This may be concluded from the following observations: (i) the existence of the intermediate state at ∼2.8M GdmCl present in the intact IgG6B3 but absent in the Fab6B3 unfolding as detected by ANS fluorescence (Fig. 5) and (ii) the destabilization of the transitions of IgG6B3WTΔ/MΔ at >2.5M compared to IgG6B3WT/M, due to the lack of glycosylation. Thus, absent glycosylation in CH2 domains and its subsequent destabilization very likely affects also the stability of the closest protein region, the CH3 domains, possibly by interactions between partially un/folded domains.
Glycosylation
Non-glycosylated forms of IgG have been produced in order to reduce effector functions, and thus to limit toxicity of some clinical candidates, such as, for example, otelixizumab (anti-CD3 IgG1),45 clazakizumab (BMS-945429, ALD518) (anti-IL-6 IgG1),46 BIIB-022 (anti-IGF-1R IgG4).47 Such non-glycosylated antibodies simplify bioprocessing, as glycan isoforms are avoided, but show a lower stability and higher aggregation tendency,23,25,27,41,42,48 as analyzed by a new DSC approach in the present work.
This lower stability may be in part due to a destabilization of the C'E loop of the CH2 domain in murine IgG149 or the DE loop and FG loop in human IgG4.50 While in wt CH2 domains contacts between the domains are entirely mediated by the sugars, the absence of glycosylation apparently leads to more degrees of freedom for domain orientation, probably also contributing to a lower stability. In crystal structures of non-glycosylated Fc regions both open conformations and “super-closed” conformations have been found.49–51 Measurements by small-angle X-ray scattering (SAXS) in solution suggest a more open orientation of the CH2 domains for the non-glycosylated Fc.51 The altered and/or disordered loop structures mentioned above are believed to contribute to the lack of Fcγ receptor binding and the reduced complement binding of non-glycosylated Fc regions,52,53 while the structure still supports similar binding to the FcRn receptor and thus a long serum half-life in humans, as evident from the clinical trials cited above.
While in the Fc part, glycosylation at Asn297 has a clear biological function—supporting binding to FcγR and complement—spurious glycosylation may occur in the variable regions when they carry an accessible Asn-X-Ser/Thr motif.53 It is even present in the marketed antibody cetuximab.54 Fab glycosylation can lead to inconsistency of binding, depending on the expression host of the recombinant antibodies, and thus, modern antibody libraries have mostly removed such motifs, and the effect of V-domain glycosylation on stability—if any—has not been well investigated.
Conclusions
In summary, in this work we (i) suggest a novel model that accurately describes the thermal denaturation of IgG molecules and (ii) derive the equations in accordance with the model to apply them in numerical analyses of thermal denaturation of two different antibodies and their mutants, monitored by DSC. Our analyses confirmed and extended previous findings, that is, that the intact IgG undergoes thermal denaturation through three cooperative transitions corresponding to reversible denaturation of CH2 domains followed by two consecutive irreversible transitions of Fab and CH3 domains. Analyses of the fitting parameters of thermal denaturation of Fab6B3 fragments and the intact IgG6B3 variants suggest that individual domains apparently “feel” the presence of each other, potentially by un/folding intermediates interacting with each other.
In fact, kinetic parameters describing thermal unfolding of the individual Fab6B3 fragment and the IgG6B3 indicate that the Fab fragment is kinetically destabilized in the context of an IgG. Moreover, stabilizing mutations make the Fab6B3M fragment less sensitive towards the unfolding of other domains of the full-length antibody, possibly as a result of the lower abilities of the unfolded domains to affect the conformational state of the more stable Fab6B3 fragment. Thus, the mutations have a greater effect on the kinetic stability of the IgG than the corresponding Fab fragment.
We believe that applying the derived equation in the analyses of thermal denaturation of immunoglobulins, under the assumption that their thermal denaturation proceeds according to the suggested model, may provide improved information regarding de/stabilization effect of modification(s) in the protein structures of individual domains and/or due to different solvent formulations. This is currently investigated in a comprehensive study and will be presented in a different manuscript.
Acknowledgments
The authors thank Dr. Yuguang Zhao (Wellcome Trust Centre for Human Genetics, Oxford University) for his active help in IgG expression. They further thank Dr. Annemarie Honegger for her help in preparing Figure 1 and the other members of the Plückthun laboratory for fruitful discussions.
Glossary
- ANS
8-anilinonaphthalene-1-sulfonate
- CH
constant domain of the heavy chain
- CL
constant domain of the light chain
- DSC
differential scanning calorimetry
- GdmCl
guanidinium chloride
- IgG
immunoglobulin G
- ITF
intrinsic tryptophan fluorescence
- PBS
phosphate-buffered saline
- SAXS
small-angle X-ray scattering
- WT
wild type
- M
mutant.
APPENDIX
The total enthalpy of the system
(using state N as the reference level) is given by
![]() |
A1 |
![]() |
A2 |
| A3 |
where
| A4 |
| A5 |
and

From Eq. 14 and Eq. (A6), neglecting the temperature dependence of
![]() |
changing the reference level
![]() |
using a system of differential equations describing the model
![]() |
A7 |
yields
and finally
| A8 |
The first two equations 17 are independent relative to the other and in such a way can be solved separately, in two steps described by two consecutive reactions:
![]() |
with corresponding molar heat capacities for reactions are expressed as:
![]() |
The corresponding fractional occupancies of states in Reaction 1, N and U are given by Sanchez-Ruiz:5
![]() |
A9 |
where
![]() |
A10 |
The fractional occupancy of state nD in Reaction 2 is given by third differential equation from system 17:
| A11 |
where nU is taken from Eq. 22. Eq. 24 represents a nonhomogenous linear differential equation, which is solved by a general method as follows: looking for a solution in the form
| A12 |
where
in Eq. 25 represents the solution of a homogenous differential equation
gives the expression for the fractional occupancy of D-state, nD:
| A13 |
Substituting the obtained values for fractional occupancies of the states N, U and D into equation for the excess heat capacity (Eq. 19) describing the thermal transitions according the model (Eq. 17) gives us a final equation:
![]() |
A14 |
Here
, K and k2 are defined by Eq. 23 and k3 and ɛ3 are defined as follows:
Supporting Information
Additional Supporting Information may be found in the online version of this article
Supporting Information
References
- Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol. 2010;10:345–352. doi: 10.1038/nri2747. [DOI] [PubMed] [Google Scholar]
- Lumry R, Eyring H. Conformation changes of proteins. J Phys Chem. 1954;58:110–120. [Google Scholar]
- Lumry R, Biltonen R. Validity of the “two-state” hypothesis for conformational transitions of proteins. Biopolymers. 1966;4:917–944. doi: 10.1002/bip.1966.360040808. [DOI] [PubMed] [Google Scholar]
- Sanchez-Ruiz JM. Protein kinetic stability. Biophys Chem. 2010;148:1–15. doi: 10.1016/j.bpc.2010.02.004. [DOI] [PubMed] [Google Scholar]
- Sanchez-Ruiz JM. Theoretical analysis of Lumry-Eyring models in differential scanning calorimetry. Biophys J. 1992;61:921–935. doi: 10.1016/S0006-3495(92)81899-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sedlák E, Zoldák G, Wittung-Stafshede P. Role of copper in thermal stability of human ceruloplasmin. Biophys J. 2008;94:1384–1391. doi: 10.1529/biophysj.107.113696. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sedlák E, Ziegler L, Kosman DJ, Wittung-Stafshede P. In vitro unfolding of yeast multicopper oxidase Fet3p variants reveals unique role of each metal site. Proc Natl Acad Sci. U S A. 2008;105:19258–19263. doi: 10.1073/pnas.0806431105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sedlák E, Varhač R, Musatov A, Robinson NC. The kinetic stability of cytochrome c oxidase: effect of bound phospholipid and dimerization. Biophys J. 2014;107:2932–2940. doi: 10.1016/j.bpj.2014.10.055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ionescu RM, Vlasak J, Price C, Kirchmeier M. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies. J Pharm Sci. 2008;97:1414–1426. doi: 10.1002/jps.21104. [DOI] [PubMed] [Google Scholar]
- Tischenko VM, Zav'yalov VP, Medgyesi GA, Potekhin SA, Privalov PL. A thermodynamic study of cooperative structures in rabbit immunoglobulin G. Eur J Biochem. 1982;126:517–521. doi: 10.1111/j.1432-1033.1982.tb06811.x. [DOI] [PubMed] [Google Scholar]
- Buchner J, Renner M, Lilie H, Hinz HJ, Jaenicke R, Kiefhaber T, Rudolph R. Alternatively folded states of an immunoglobulin. Biochemistry. 1991;30:6922–6929. doi: 10.1021/bi00242a016. [DOI] [PubMed] [Google Scholar]
- Martsev SP, Kravchuk ZI, Vlasov AP, Lyakhnovich GV. Thermodynamic and functional characterization of a stable IgG conformer obtained by renaturation from a partially structured low pH-induced state. FEBS Lett. 1995;361:173–175. doi: 10.1016/0014-5793(95)00145-y. [DOI] [PubMed] [Google Scholar]
- Vlasov AP, Kravchuk ZI, Martsev SP. Non-native conformational states of immunoglobulins: thermodynamic and functional studies of rabbit IgG. Biochemistry (Moscow) 1996;61:155–171. [PubMed] [Google Scholar]
- Ejima D, Tsumoto K, Fukada H, Yumioka R, Nagase K, Arakawa T, Philo JS. Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies. Proteins. 2007;66:954–962. doi: 10.1002/prot.21243. [DOI] [PubMed] [Google Scholar]
- Kamerzell TJ, Ramsey JD, Middaugh CR. Immunoglobulin dynamics, conformational fluctuations, and nonlinear elasticity and their effects on stability. J Phys Chem B. 2008;112:3240–3250. doi: 10.1021/jp710061a. [DOI] [PubMed] [Google Scholar]
- Ahrer K, Buchacher A, Iberer G, Jungbauer A. Thermodynamic stability and formation of aggregates of human immunoglobulin G characterised by differential scanning calorimetry and dynamic light scattering. J Biochem Biophys Methods. 2006;66:73–86. doi: 10.1016/j.jbbm.2005.12.003. [DOI] [PubMed] [Google Scholar]
- Harn N, Allan C, Oliver C, Middaugh CR. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability. J Pharm Sci. 2007;96:532–546. doi: 10.1002/jps.20753. [DOI] [PubMed] [Google Scholar]
- Shimba N, Torigoe H, Takahashi H, Masuda K, Shimada I, Arata Y, Sarai A. Comparative thermodynamic analyses of the Fv, Fab* and Fab fragments of anti-dansyl mouse monoclonal antibody. FEBS Lett. 1995;360:247–250. doi: 10.1016/0014-5793(95)00113-n. [DOI] [PubMed] [Google Scholar]
- Vermeer AW, Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys J. 2000;78:394–404. doi: 10.1016/S0006-3495(00)76602-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Manly SP, Matthews KS, Sturtevant JM. Thermal denaturation of the core protein of lac repressor. Biochemistry. 1985;24:3842–3846. doi: 10.1021/bi00336a004. [DOI] [PubMed] [Google Scholar]
- Edge V, Allewell NM, Sturtevant JM. High-resolution differential scanning calorimetric analysis of the subunits of Escherichia coli aspartate transcarbamoylase. Biochemistry. 1985;24:5899–5906. doi: 10.1021/bi00342a032. [DOI] [PubMed] [Google Scholar]
- Hu CQ, Sturtevant JM. Thermodynamic study of yeast phosphoglycerate kinase. Biochemistry. 1987;26:178–182. doi: 10.1021/bi00375a025. [DOI] [PubMed] [Google Scholar]
- Schaefer JV, Plückthun A. Transfer of engineered biophysical properties between different antibody formats and expression systems. Protein Eng Des Sel. 2012;25:485–506. doi: 10.1093/protein/gzs039. [DOI] [PubMed] [Google Scholar]
- Ewert S, Huber T. A Honegger, A Plückthun. Biophysical properties of human antibody variable domains. J Mol Biol. 2003;325:531–553. doi: 10.1016/s0022-2836(02)01237-8. [DOI] [PubMed] [Google Scholar]
- Liu H, Bulseco GG, Sun J. Effect of posttranslational modifications on the thermal stability of a recombinant monoclonal antibody. Immunol Lett. 2006;106:144–153. doi: 10.1016/j.imlet.2006.05.011. [DOI] [PubMed] [Google Scholar]
- Garber E, Demarest SJ. A broad range of Fab stabilities within a host of therapeutic IgGs. Biochem Biophys Res Commun. 2007;355:751–757. doi: 10.1016/j.bbrc.2007.02.042. [DOI] [PubMed] [Google Scholar]
- Schaefer JV, Plückthun A. Engineering aggregation resistance in IgG by two independent mechanisms: lessons from comparison of Pichia pastoris and mammalian cell expression. J Mol Biol. 2012;417:309–335. doi: 10.1016/j.jmb.2012.01.027. [DOI] [PubMed] [Google Scholar]
- Zoldák G, Zubrik A, Musatov A, Stupák M, Sedlák E. Irreversible thermal denaturation of glucose oxidase from Aspergillus niger is the transition to the denatured state with residual structure. J Biol Chem. 2004;279:47601–47609. doi: 10.1074/jbc.M406883200. [DOI] [PubMed] [Google Scholar]
- Wakankar AA, Feeney MB, Rivera J, Chen Y, Kim M, Sharma VK, Wang YJ. Physicochemical stability of the antibody-drug conjugate Trastuzumab-DM1: changes due to modification and conjugation processes. Bioconjug Chem. 2010;21:1588–1595. doi: 10.1021/bc900434c. [DOI] [PubMed] [Google Scholar]
- Sánchez-Ruiz JM, López-Lacomba JL, Cortijo M, Mateo PL. Differential scanning calorimetry of the irreversible thermal denaturation of thermolysin. Biochemistry. 1988;27:1648–1652. doi: 10.1021/bi00405a039. [DOI] [PubMed] [Google Scholar]
- Burstein EA, Vedenkina NS, Ivkova MN. Fluorescence and the location of tryptophan residues in protein molecules. Photochem Photobiol. 1973;18:263–279. doi: 10.1111/j.1751-1097.1973.tb06422.x. [DOI] [PubMed] [Google Scholar]
- Semisotnov GV, Rodionova NA, Razgulyaev OI, Uversky VN, Gripas' AF, Gilmanshin RI. Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers. 1991;31:119–128. doi: 10.1002/bip.360310111. [DOI] [PubMed] [Google Scholar]
- Hawe A, Sutter M, Jiskoot W. Extrinsic fluorescent dyes as tools for protein characterization. Pharm Res. 2008;25:1487–1499. doi: 10.1007/s11095-007-9516-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Röthlisberger D, Honegger A, Plückthun A. Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability. J Mol Biol. 2005;347:773–789. doi: 10.1016/j.jmb.2005.01.053. [DOI] [PubMed] [Google Scholar]
- Bushmarina NA, Kuznetsova IM, Biktashev AG, Turoverov KK, Uversky VN. Partially folded conformations in the folding pathway of bovine carbonic anhydrase II: a fluorescence spectroscopic analysis. ChemBioChem. 2001;2:813–821. doi: 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W. [DOI] [PubMed] [Google Scholar]
- Kuznetsova IM, Stepanenko OV, Turoverov KK, Zhu L, Zhou JM, Fink AL, Uversky VN. Unraveling multistate unfolding of rabbit muscle creatine kinase. Biochim Biophys Acta. 2002;1596:138–155. doi: 10.1016/s0167-4838(02)00212-1. [DOI] [PubMed] [Google Scholar]
- Kuznetsova IM, Turoverov KK, Uversky VN. Use of the phase diagram method to analyze the protein unfolding-refolding reactions: fishing out the “invisible” intermediates. J Proteome Res. 2004;3:485–494. doi: 10.1021/pr034094y. [DOI] [PubMed] [Google Scholar]
- Zoldák G, Sedlák E, Wolfrum A, Musatov A, Fedunová D, Szkaradkiewicz K, Sprinzl M. Multidomain initiation factor 2 from Thermus thermophilus consists of the individual autonomous domains. Biochemistry. 2008;47:4992–5005. doi: 10.1021/bi702295g. [DOI] [PubMed] [Google Scholar]
- Welfle K, Misselwitz R, Hausdorf G, Höhne W, Welfle H. Conformation, pH-induced conformational changes, and thermal unfolding of anti-p24 (HIV-1) monoclonal antibody CB4-1 and its Fab and Fc fragments. Biochim Biophys Acta. 1999;1431:120–131. doi: 10.1016/s0167-4838(99)00046-1. [DOI] [PubMed] [Google Scholar]
- Demarest SJ, Chen G, Kimmel BE, Gustafson D, Wu J, Salbato J, Poland J, Elia M, Tan X, Wong K, Short J, Hansen G. Engineering stability into Escherichia coli secreted Fabs leads to increased functional expression. Protein Eng Des Sel. 2006;19:325–336. doi: 10.1093/protein/gzl016. [DOI] [PubMed] [Google Scholar]
- Ghirlando R, Lund J, Goodall M, Jefferis R. Glycosylation of human IgG-Fc: influences on structure revealed by differential scanning micro-calorimetry. Immunol Lett. 1999;68:47–52. doi: 10.1016/s0165-2478(99)00029-2. [DOI] [PubMed] [Google Scholar]
- Mimura Y, Church S, Ghirlando R, Ashton PR, Dong S, Goodall M, Lund J, Jefferis R. The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms. Mol Immunol. 2000;37:697–706. doi: 10.1016/s0161-5890(00)00105-x. [DOI] [PubMed] [Google Scholar]
- Alsenaidy MA, Kim JH, Majumdar R, Weis DD, Joshi SB, Tolbert TJ, Middaugh CR, Volkin DB. High-throughput biophysical analysis and data visualization of conformational stability of an IgG1 monoclonal antibody after deglycosylation. J Pharm Sci. 2013;102:3942–3956. doi: 10.1002/jps.23730. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alsenaidy MA, Okbazghi SZ, Kim JH, Joshi SB, Middaugh CR, Tolbert TJ, Volkin DB. Physical stability comparisons of IgG1-Fc variants: effects of N-glycosylation site occupancy and Asp/Gln residues at site Asn 297. J Pharm Sci. 2014;103:1613–1627. doi: 10.1002/jps.23975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aronson R, Gottlieb PA, Christiansen JS, Donner TW, Bosi E, Bode BW, Pozzilli P. Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes. DEFEND Investigator Group. Diabetes Care. 2014;37:2746–2754. doi: 10.2337/dc13-0327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mease P, Strand V, Shalamberidze L, Dimic A, Raskina T, Xu LA, Liu Y, Smith J. A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate. Ann Rheum Dis. 2012;71:1183–1189. doi: 10.1136/annrheumdis-2011-200704. [DOI] [PubMed] [Google Scholar]
- von Mehren M, Britten CD, Pieslor P, Saville W, Vassos A, Harris S, Galluppi GR, Darif M, Wainberg ZA, Cohen RB, Leong S. A phase 1, open-label, dose-escalation study of BIIB022 (anti-IGF-1R monoclonal antibody) in subjects with relapsed or refractory solid tumors. Invest New Drugs. 2014;32:518–525. doi: 10.1007/s10637-014-0064-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kayser V, Chennamsetty N, Voynov V, Forrer K, Helk B, Trout BL. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies. Biotechnol J. 2011;6:38–44. doi: 10.1002/biot.201000091. [DOI] [PubMed] [Google Scholar]
- Feige MJ, Nath S, Catharino SR, Weinfurtner D, Steinbacher S, Buchner J. Structure of the murine unglycosylated IgG1 Fc fragment. J Mol Biol. 2009;391:599–608. doi: 10.1016/j.jmb.2009.06.048. [DOI] [PubMed] [Google Scholar]
- Davies AM, Jefferis R, Sutton BJ. Crystal structure of deglycosylated human IgG4-Fc. Mol Immunol. 2014;62:46–53. doi: 10.1016/j.molimm.2014.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Borrok MJ, Jung ST, Kang TH, Monzingo AF, Georgiou G. Revisiting the role of glycosylation in the structure of human IgG Fc. ACS Chem Biol. 2012;7:1596–1602. doi: 10.1021/cb300130k. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lund J, Takahashi N, Pound JD, Goodall M, Jefferis R. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fcγ receptor I and influence the synthesis of its oligosaccharide chains. J Immunol. 1996;157:4963–4969. [PubMed] [Google Scholar]
- Hayes JM, Cosgrave EF, Struwe WB, Wormald M, Davey GP, Jefferis R, Rudd PM. Glycosylation and Fc receptors. Curr Top Microbiol Immunol. 2014;382:165–199. doi: 10.1007/978-3-319-07911-0_8. [DOI] [PubMed] [Google Scholar]
- Ayoub D, Jabs W, Resemann A, Evers W, Evans C, Main L, Baessmann C, Wagner-Rousset E, Suckau D, Beck A. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. mAbs. 2013;5:699–710. doi: 10.4161/mabs.25423. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supporting Information













